ASCO Guidelines

40
Medicine #200

Explore pivotal recommendations from the latest evidence-based clinical practice guidance with ASCO Guidelines. Join us to discover essential insights and navigate the ever-evolving landscape of cancer research and treatment.

Recent Episodes
  • Sentinel Lymph Node Biopsy in Early-Stage Breast Cancer Guideline Update
    Apr 10, 2025 – 20:51
  • Fertility Preservation in People with Cancer Guideline Update
    Mar 19, 2025 – 32:09
  • Opioid Conversion in Adults with Cancer: MASCC-ASCO-AAHPM-HPNA-NICSO Guideline
    Mar 5, 2025 – 20:19
  • Therapy for Stage IV NSCLC Without Driver Alterations: ASCO Living Guideline Update 2024.3 Part 1
    Feb 27, 2025 – 10:48
  • Therapy for Stage IV NSCLC With Driver Alterations: ASCO Living Guideline Update 2024.3 Part 2
    Feb 27, 2025 – 15:20
  • TORS in the Multidisciplinary Care of Patients with Oropharyngeal Squamous Cell Carcinoma Guideline
    Feb 11, 2025 – 22:28
  • Neoadjuvant Chemotherapy for Newly Diagnosed, Advanced Ovarian Cancer Guideline Update
    Jan 22, 2025 – 19:04
  • Germline and Somatic Genomic Testing for Metastatic Prostate Cancer Guideline
    Jan 9, 2025 – 16:25
  • Treatment of Pleural Mesothelioma Update
    Jan 8, 2025 – 10:37
  • Systemic Therapy for Stage I-III Anal Squamous Cell Carcinoma Guideline
    Dec 16, 2024 – 16:14
  • Systemic Therapy for SCLC Rapid Update
    Nov 20, 2024 – 14:28
  • Therapy for Stage IV NSCLC With Driver Alterations: ASCO Living Guideline Update 2024.2
    Nov 12, 2024 – 09:53
  • Management of Locally Advanced Rectal Cancer Guideline
    Aug 8, 2024 – 12:23
  • Management of Stage III NSCLC Rapid Update
    Jul 23, 2024 – 08:02
  • Selection of Germline Genetic Testing Panels in Patients with Cancer Guideline
    Jun 20, 2024 – 17:44
  • Therapy for Stage IV NSCLC With Driver Alterations: ASCO Living Guideline Update 2024.1
    May 30, 2024 – 12:24
  • Antineoplastic Therapy Administration Safety Standards for Adult and Pediatric Oncology: ASCO-ONS Standards
    May 22, 2024 – 17:52
  • Optimal Adjuvant Chemotherapy and Targeted Therapy for Early Breast Cancer – CDK4/6 Inhibitors Rapid Update
    May 20, 2024 – 11:23
  • Management of Fatigue in Adult Survivors of Cancer: ASCO-SIO Guideline Update
    May 16, 2024 – 19:24
  • Palliative Care for Patients with Cancer Guideline Update
    May 15, 2024 – 20:30
  • Prevention and Management of Osteoradionecrosis in Patients with Head and Neck Cancer Treated with Radiation Therapy: ISOO-MASCC-ASCO Guideline
    May 1, 2024 – 20:10
  • Survivorship Care for People Affected by Advanced or Metastatic Cancer: MASCC-ASCO Standards and Practice Recommendations
    Apr 29, 2024 – 21:39
  • Systemic Therapy for Advanced Hepatocellular Carcinoma Guideline Update
    Mar 19, 2024 – 15:28
  • Vaccination of Adults with Cancer Guideline
    Mar 18, 2024 – 18:22
  • Cannabis and Cannabinoids in Adults with Cancer Guideline
    Mar 13, 2024 – 16:13
  • Endocrine and Targeted Therapy for HR-Positive, HER2-Negative Metastatic Breast Cancer – Capivasertib-Fulvestrant: Rapid Guideline Update
    Mar 13, 2024 – 14:09
  • Therapy for Stage IV NSCLC With Driver Alterations: ASCO Living Guideline Update 2023.3 Part 2
    Feb 28, 2024 – 14:23
  • Therapy for Stage IV NSCLC Without Driver Alterations: ASCO Living Guideline Update 2023.3 Part 1
    Feb 28, 2024 – 09:49
  • Systemic Treatment of Patients with Metastatic Breast Cancer Resource-Stratified Guideline
    Jan 10, 2024 – 19:03
  • Germline Testing in Patients with Breast Cancer: ASCO-SSO Guideline
    Jan 4, 2024 – 16:26
  • Systemic Therapy Update on 177Lutetium-PSMA-617 for Metastatic Castration-Resistant Prostate Cancer: ASCO Rapid Recommendation Update
    Nov 6, 2023 – 09:56
  • Systemic Therapy for SCLC: ASCO-OH (CCO) Guideline
    Oct 11, 2023 – 27:13
  • Management of Metastatic Renal Clear Cell Cancer Rapid Recommendation Update
    Oct 10, 2023 – 07:48
  • Systemic Therapy for Tumor Control in Metastatic Well-Differentiated GEP-NETs Guideline
    Sep 29, 2023 – 18:47
  • Systemic Therapy for Melanoma Guideline Update
    Sep 6, 2023 – 16:35
  • Integrative Oncology Care of Symptoms of Anxiety and Depression in Adults with Cancer: SIO-ASCO Guideline
    Aug 15, 2023 – 14:22
  • Management of Stage III NSCLC Rapid Recommendation Update
    Jul 20, 2023 – 08:14
  • Practical Assessment and Management of Vulnerabilities in Older Patients Receiving Systemic Cancer Therapy Guideline Update
    Jul 17, 2023 – 23:09
  • Cancer Cachexia Rapid Recommendation Update
    Jul 12, 2023 – 08:55
  • Therapy for Stage IV NSCLC With Driver Alterations: ASCO Living Guideline Update 2023.2
    Jul 11, 2023 – 07:30
  • HER2 Testing in Breast Cancer: ASCO-CAP Guideline Update
    Jun 7, 2023 – 24:56
  • Testing for ESR1 Mutations to Guide Therapy for HR-Positive, HER2-Negative Metastatic Breast Cancer Rapid Recommendation Update
    May 17, 2023 – 10:42
  • VTE Prophylaxis and Treatment in Patients with Cancer Guideline Update
    Apr 19, 2023 – 14:05
  • Management of Anxiety and Depression in Adult Survivors of Cancer Guideline Update
    Apr 19, 2023 – 12:15
  • Therapy for Stage IV NSCLC With Driver Alterations: ASCO Living Guideline Update 2023.1 Part 2
    Apr 6, 2023 – 09:21
  • Therapy for Stage IV NSCLC Without Driver Alterations: ASCO Living Guideline Update 2023.1 Part 1
    Apr 6, 2023 – 11:24
  • Initial Management of Noncastrate Advanced, Recurrent, or Metastatic Prostate Cancer Guideline Update
    Apr 3, 2023 – 08:52
  • Penile Cancer: EAU-ASCO Guideline
    Mar 10, 2023 – 17:48
  • Chemotherapy and Targeted Therapy for Endocrine-Pretreated or Hormone Receptor–Negative Metastatic Breast Cancer Rapid Recommendation Update
    Jan 20, 2023 – 07:07
  • Mismatch Repair and Microsatellite Instability Testing for Immune Checkpoint Inhibitor Therapy: ASCO Endorsement of CAP Guideline
    Jan 6, 2023 – 16:31
Recent Reviews
Reviews loading...
Similar Podcasts
Disclaimer: The podcast and artwork on this page are property of the podcast owner, and not endorsed by UP.audio.